CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells

Area of Science:

• Immunology
• Cell Biology
• Autoimmunity

Background:

• CD4+CD25+ T regulatory (Treg) cells are vital for preventing autoimmune diseases.
• Treg cell-mediated suppression of conventional T cells requires cell-cell contact, but the specific molecules involved remain unidentified.
• LFA-1 (CD11a/CD18) is an adhesion molecule known for its role in T cell activation and contact, and it is highly expressed on Treg cells.

Purpose of the Study:

• To investigate the role of LFA-1 (CD11a/CD18) in the development and function of murine CD4+CD25+ Treg cells.
• To determine if LFA-1 is essential for Treg cell-mediated suppression and protection against autoimmune conditions.

Main Methods:

• Analysis of LFA-1-deficient (CD18-/-) mice and their CD4+CD25+ T cells.
• Assessment of Treg cell numbers, thymic, and peripheral development in CD18-/- mice.
• In vitro suppression assays using LFA-1-deficient Treg cells.
• In vivo colitis models using CD4+CD25- T cell transfer into lymphopenic hosts.

Main Results:

• CD18-/- mice exhibited a predisposition to autoimmunity.
• Absence of CD18 resulted in reduced numbers of CD4+CD25+ T cells and impaired thymic and peripheral development.
• LFA-1-deficient CD4+CD25+ T cells showed diminished suppressive capacity in vitro.
• LFA-1-deficient Treg cells failed to protect against colitis induction in vivo.

Conclusions:

• CD18 plays a critical role in the optimal development and function of CD4+CD25+ Treg cells.
• LFA-1 is essential for Treg cell-mediated immune suppression and the prevention of autoimmune diseases like colitis.